Login / Signup

Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study.

Omar ElkayalBeatrijs MertensJoost WautersYves DebaveyeBart J A RijndersPaul E VerweijRoger J M BrüggemannIsabel SprietErwin Dreesen
Published in: The Journal of antimicrobial chemotherapy (2024)
We have defined a convenient, optimized IV posaconazole dosing regimen that was predicted to attain the treatment target in critically ill patients with invasive aspergillosis.
Keyphrases
  • pulmonary hypertension
  • replacement therapy